Zizyberanal acid - Compound Card

Zizyberanal acid

Select a section from the left sidebar

Zizyberanal acid

Structure
Zoomed Structure
  • Family: Plantae - Vitaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene
Canonical Smiles OC[C@H]1CC(C2[C@@]1(C)C1CCC3[C@]([C@@]1(CC2)C)(CC[C@@]1(C3[C@@H](CC1)C(=C)C)C(=O)O)C(=O)O)(C)C
InChI InChI=1S/C30H46O5/c1-17(2)19-9-12-29(24(32)33)13-14-30(25(34)35)20(23(19)29)7-8-22-27(30,5)11-10-21-26(3,4)15-18(16-31)28(21,22)6/h18-23,31H,1,7-16H2,2-6H3,(H,32,33)(H,34,35)/t18-,19+,20?,21?,22?,23?,27-,28+,29+,30-/m1/s1
InChIKey HNQFXRQBVKRLFF-UUMKRNLVSA-N
Formula C30H46O5
HBA 3
HBD 3
MW 486.69
Rotatable Bonds 4
TPSA 94.83
LogP 6.01
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 35
Formal Charge 0
Fraction CSP3 0.87
Exact Mass 486.33
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Cyphostemma adenocaule Vitaceae Plantae 1236437

Showing of synonyms

  • Chouna JR, Nardella F, et al. (2016). Ceanothane-type triterpenoids from Cyphostemma adenocaule.. Archives of pharmacal research,2016. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCC(C12)CCC3C2CCC4C5C(CCC5)CCC34

Level: 0

Mol. Weight: 486.69 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.44
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.210
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.78

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.510
Plasma Protein Binding
81.69
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
1.680
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-2.080
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.580
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
2.350
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-280.860
Rat (Acute)
2.320
Rat (Chronic Oral)
2.630
Fathead Minnow
3.950
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
485.980
Hydration Free Energy
-2.810
Log(D) at pH=7.4
1.930
Log(P)
4.54
Log S
-5.6
Log(Vapor Pressure)
-11.73
Melting Point
301.72
pKa Acid
4.48
pKa Basic
8.92
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Branched-chain-amino-acid aminotransferase, mitochondrial O15382 BCAT2_HUMAN Homo sapiens 3 0.7262
Methylketone synthase I E0YCS2 E0YCS2_SOLHA Solanum habrochaites 3 0.7191
Abscisic acid receptor PYL3 Q9SSM7 PYL3_ARATH Arabidopsis thaliana 3 0.7140

Download SDF